Potential Role of Acupuncture Treatment in Neuronal and Network Dysfunction in Patients With Vascular Cognitive Impairment
Vascular cognitive impairment (VCI) is a broad dimensional term, ranging from mild cognitive impairment without incapacity on activity of daily living to vascular dementia (VaD), referred to as significant cognitive impairment and decline in function status.
In this three-year project, we aim to evaluate the effects of biochemical data, early clinical variables, neuroimaging results, and intervention of acupuncture treatment on vascular event related cognitive impairment in crossectional analysis and longitudinal follow-up.
Tutkimuksen yleiskatsaus
Tila
Interventio / Hoito
Yksityiskohtainen kuvaus
Stroke is a common cerebrovascular disease of the central nervous system leading to serious medical complication. It results in a high mortality rate and increased disability rate. Stroke survivors may have long-lasting consequences, including motor dysfunction, sensibility dysfunction, and cognitive impairment]. Cognition is a key component of rehabilitation and recovery; therefore it is associated with poor engagement in rehabilitee and outcomes including increased mortality. As vascular dementia (VaD) is considered the second-most-common type of dementing illness, accounting for a significant proportion of total dementia case, vascular cognitive impairment (VCI) is a broader dimensional term, ranging from mild cognitive impairment without incapacity on activity of daily living to VaD, referred to as significant cognitive impairment and decline in function status.
Acupuncture is an ancient Chinese medical technique in which fine, stainless steel needles are inserted into certain anatomical locations of the body surface to elicit neurohormonal responses of the body system via nerve stimulation. Acupuncture are reported to be probably effective in improving cognitive function in vascular dementia animal models via multiple mechanisms such as anti-apoptosis, antioxidative stress reaction, and metabolism enhancing of glucose and oxygen.
Motor features may not parallel to the cognitive changes, it will serve as the disease progression marker. Unified Parkinson's Disease Rating Scale (UPDRS)-part III scores and NIH Stroke Scale (NIHSS) will be used.
- At Kaohsiung Chang Gung Memorial Hospital, all the patients (n=80) will be included and receive a Standardized Acupuncture intervention; 40 will be treated with regular medication; 40 will be treated with acupuncture and regular medication.
- For acupressure program, all participants are treated in supine position, and a certified TCM physician applied firm pressure (3 to 5 kg of pressure) with fingertips in a circular motion at a speed of 2 circles per second for a duration of one minute per acupoint. The complete process lasts for 8 minutes.
Cognitive function, Motor function, Mood and Sleep will be evaluated at baseline and follow-up period of time at 3 month, 6 month, and 12 month.
Opintotyyppi
Ilmoittautuminen (Odotettu)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskelupaikat
-
-
-
Kaohsiung, Taiwan, 83301
- Rekrytointi
- Kaohsiung Chang Gung Memorial Hospital
-
Ottaa yhteyttä:
- YaTing Chang
- Puhelinnumero: 077317123
- Sähköposti: emily0606@cgmh.org.tw
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
1. Fulfill the diagnostic criteria of vascular cognitive impairment
Exclusion Criteria:
- Systemic inflammatory disease with on-going treatment
- Severe psychiatric disease, such as major depressive disorder or schizophrenia
- Severe traumatic brain injury
- Unable to tolerate exam of brain MRI
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Ennaltaehkäisy
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Kolminkertaistaa
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Huijausvertailija: regular medication treatment
|
acupuncture treatment on selected acupoint
|
|
Kokeellinen: acupuncture and regular medication treatment
|
acupuncture treatment on selected acupoint
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Change from baseline sleep quality at 3 months, 6 months, 12 months
Aikaikkuna: 3 months, 6 months, 12 months
|
Analogous variables were extracted from actigraphy.
The sleep variables collected were sleep start time, sleep end time, sleep duration, sleep efficiency, and wake after sleep onset time, and the activity variables collected were heart rate activity score,activity amount, and activity intensity
|
3 months, 6 months, 12 months
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Change from baseline neuro-behavioral performances at 3 months, 6 months, 12 months
Aikaikkuna: 3 months, 6 months, 12 months
|
Cognitive Abilities Screening Instrument (CASI).
In addition to general cognitive performance, CASI was used to evaluate specific domains, including short-term memory, attention and concentration, abstraction, visual construction, language, and list-generating fluency.
|
3 months, 6 months, 12 months
|
|
Change from baseline motor function (UPDRS) at 3 months, 6 months, 12 months
Aikaikkuna: 3 months, 6 months, 12 months
|
Unified Parkinson's Disease Rating Scale (UPDRS)-part III scores for parkinsonian features.
|
3 months, 6 months, 12 months
|
|
Change from baseline motor function (NIHSS) at 3 months, 6 months, 12 months
Aikaikkuna: 3 months, 6 months, 12 months
|
NIH Stroke Scale (NIHSS) score 0-24.
|
3 months, 6 months, 12 months
|
|
Change from baseline continuous motor function at 3 months, 6 months, 12 months
Aikaikkuna: 3 months, 6 months, 12 months
|
Physical activity was measured using accelerometers.
|
3 months, 6 months, 12 months
|
|
Change from baseline memory performances at 3 months, 6 months, 12 months
Aikaikkuna: 3 months, 6 months, 12 months
|
Verbal memory were evaluated by using Chinese Version Verbal Learning Test (CVVLT).Visual-spatial abilities.
|
3 months, 6 months, 12 months
|
|
Change from baseline executive performances at 3 months, 6 months, 12 months
Aikaikkuna: 3 months, 6 months, 12 months
|
Attention and executive function was evaluated by Trail Making Test B.
|
3 months, 6 months, 12 months
|
|
Change from baseline executive performances (Stroop interference test) at 3 months, 6 months, 12 months
Aikaikkuna: 3 months, 6 months, 12 months
|
Attention and executive function was evaluated by Stroop interference test.
|
3 months, 6 months, 12 months
|
|
Change from baseline executive performances (calculation) at 3 months, 6 months, 12 months
Aikaikkuna: 3 months, 6 months, 12 months
|
As the calculation ability depends on executive function, calculation ability was evaluated to reflect part of executive function.
|
3 months, 6 months, 12 months
|
|
Change from baseline abstract thinking at 3 months, 6 months, 12 months
Aikaikkuna: 3 months, 6 months, 12 months
|
Abstract reasoning was evaluated by using similarities (conceptualization) in frontal assessment battery-Similarities.
|
3 months, 6 months, 12 months
|
|
Change from baseline language performances at 3 months, 6 months, 12 months
Aikaikkuna: 3 months, 6 months, 12 months
|
Boston Naming Test were used to evaluate language ability in naming.
|
3 months, 6 months, 12 months
|
|
Change from baseline fluency performances at 3 months, 6 months, 12 months
Aikaikkuna: 3 months, 6 months, 12 months
|
Semantic category fluency.
|
3 months, 6 months, 12 months
|
|
Change from baseline neuropsychiatric symptoms at 3 months, 6 months, 12 months
Aikaikkuna: 3 months, 6 months, 12 months
|
The neuropsychiatric symptoms of the participants were measured using the Neuropsychiatric Inventory.
|
3 months, 6 months, 12 months
|
Yhteistyökumppanit ja tutkijat
Sponsori
Tutkijat
- Päätutkija: YaTing Chang, MD,PhD, Chang Gung Memorial Hospital
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Odotettu)
Opintojen valmistuminen (Odotettu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- 201802103A3
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .